Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice

This study evaluates the antitumor efficacy of hesperidin (Hesp) versus cisplatin (Cis) in Ehrlich ascites carcinoma (EAC)-bearing mice, as well as its protective effect against Cis-triggered nephrotoxicity. Seventy female mice were allocated into control, Hesp, EAC, Hesp-protected, Hesp-treated, Ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Nahed, Allam, Tamer, Korany, Reda M. S., Abdelfattah, Abdelfattah M., Omran, Ahmed M., Abd Eldaim, Mabrouk Attia, Hassan, Aziza M., El-Borai, Nermeen Borai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953897/
https://www.ncbi.nlm.nih.gov/pubmed/35337092
http://dx.doi.org/10.3390/ph15030294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953897/
https://www.ncbi.nlm.nih.gov/pubmed/35337092
http://dx.doi.org/10.3390/ph15030294

Ejemplares similares